Clinical Trials Arena on MSN

Mabwell’s mAb leads to 40% reduction in severe COPD exacerbations

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.
The American Journal of Managed Care

Telehealth Model Reduces Hospital Admissions in COPD

Remote interventions reduced hospital readmissions by over 50% in COPD patients, highlighting their potential to disrupt frequent exacerbation cycles. Significant improvements in quality of life were ...

Smoking, air pollution among key risk factors for chronic lung disease CoPD. What you need to know about cost, symptoms, treatment

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...